CSTL
Castle Biosciences, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$32.91
+0.80%Margins
Gross margin
77.3%
EBITDA margin
-0.9%
EBIT margin
-9.0%
Net margin
-5.4%
FCF margin
-0.1%
-4.1%
Return on equity
-3.5%
Return on assets
-6.3%
Return on invested capital
0.64x
Asset turnover
$42.6M
Cash from operations
$8.73
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026